Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis
This study is a single center, randomized, double-blind, Vehicle controlled,, single and multiple dose clinical study.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
This clinical trial is a multicenter, randomized, double-blind, controlled phase II clinical study.
A Randomized, Double-blind, Dose-escalating, Placebo-controlled Phase Ib Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.
This is a randomized, double-blind, dose-escalating, placebo-controlled phase Ib clinical study.
100 Clinical Results associated with Jiangsu vcare pharmaceutical technology co., LTD
0 Patents (Medical) associated with Jiangsu vcare pharmaceutical technology co., LTD
100 Deals associated with Jiangsu vcare pharmaceutical technology co., LTD
100 Translational Medicine associated with Jiangsu vcare pharmaceutical technology co., LTD